Alberta Investment Management Corp Buys Shares of 10,300 Oscar Health, Inc. (NYSE:OSCR)

Alberta Investment Management Corp bought a new stake in Oscar Health, Inc. (NYSE:OSCR) during the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 10,300 shares of the company’s stock, valued at approximately $138,000.

Other institutional investors also recently bought and sold shares of the company. KBC Group NV lifted its holdings in Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after acquiring an additional 2,555 shares during the period. ORG Wealth Partners LLC bought a new position in Oscar Health in the fourth quarter valued at about $100,000. SMART Wealth LLC bought a new position in Oscar Health in the fourth quarter valued at about $180,000. Tempus Wealth Planning LLC bought a new position in Oscar Health in the fourth quarter valued at about $181,000. Finally, Aigen Investment Management LP bought a new position in Oscar Health in the third quarter valued at about $205,000. Institutional investors own 75.70% of the company’s stock.

Analysts Set New Price Targets

OSCR has been the subject of a number of analyst reports. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target for the company. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $21.56.

Oscar Health Stock Performance

NYSE:OSCR opened at $14.81 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12-month low of $12.43 and a 12-month high of $23.79. The stock has a 50-day moving average price of $14.82 and a 200 day moving average price of $16.68. The stock has a market capitalization of $3.66 billion, a P/E ratio of -740.33 and a beta of 1.73.

Oscar Health (NYSE:OSCR) last released its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Equities research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 6,516 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $117,809.28. Following the completion of the transaction, the insider now owns 81,962 shares in the company, valued at $1,481,872.96. This trade represents a 7.36 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CAO Victoria Baltrus sold 8,078 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at $2,640,330.88. This represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 78,610 shares of company stock worth $1,421,269. 25.11% of the stock is owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.